Biolegend, 127623, APC/Cyanine7 anti-mouse Ly-6G Antibody, 25μg

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Ly-6G transfected EL-4J cell line.
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Red Laser (633 nm)
Application Notes: While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416. Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).
Application References(PubMed link indicates BioLegend citation): Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC) Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC) Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC) Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC) Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC) Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC) Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete) Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete) Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete) Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed Ma C, et al. 2012. J. Leukoc. Biol. 92:1199. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Däbritz J, et al. 2016. Sci Rep. 6:20584. PubMed Zaman R, et al. 2021. Immunity. :. PubMed Ho YH, et al. 2019. Cell Stem Cell. 25:407. PubMed Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed Yu X, et al. 2020. Nat Commun. 11:1110. PubMed Wiedemann SJ, et al. 2022. Cell Metab. 34:991. PubMed Zheng Y, et al. 2022. Proc Natl Acad Sci U S A. 119:e2121077119. PubMed Pérez-Torrado V, et al. 2022. Bio Protoc. 12:. PubMed Ivan DC, et al. 2023. Acta Neuropathol Commun. 11:35. PubMed Chung KJ, et al. 2023. Int J Mol Sci. 24:. PubMed Houlder E, et al. 2023. Nat Commun. 14:1863. PubMed Hernandez VG, et al. 2023. Glia. 71:1960. PubMed Scieszka DP, et al. 2023. Respir Res. 24:138. PubMed Yashchenko A, et al. 2023. Front Immunol. 14:1082078. PubMed Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed Kfoury YS, et al. 2021. Cell Stem Cell. 28:2090. PubMed Tan YY, et al. 2022. Bio Protoc. 12:e4307. PubMed Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed McCauley KE, et al. 2022. Cell Rep Med. 3:100713. PubMed Foo CX, et al. 2023. Eur Respir J. 61: . PubMed Klapproth E, et al. 2022. Nat Commun. 13:7648. PubMed Chen O, et al. 2023. J Clin Invest. 133: . PubMed Li J, et al. 2023. Nat Commun. 14:159. PubMed Xu R 2023. Cell Reports. 42(2):112054. PubMed Tunali G, et al. 2023. J Clin Invest. :. PubMed Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed Kaczanowska S, et al. 2021. Cell. 184(8):2033-2052.e21. PubMed Kim EH, et al. 2020. Elife. 9:00. PubMed Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed Hastings AK, et al. 2019. iScience. 13:339. PubMed Regev O, et al. 2022. Front Immunol. 13:849701. PubMed Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed Deng J, et al. 2021. JCI Insight. 6:146133. PubMed Price P, et al. 2014. J Virol. 88:10840. PubMed Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed Minutti CM, et al. 2019. Immunity. 50:645. PubMed Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed Frank AC, et al. 2021. Theranostics. 11:7570. PubMed Weigert A, et al. 2022. Nat Commun. 13:6078. PubMed Forte D, et al. 2020. Cell Metab. 32:829. PubMed Huard A, et al. 2021. J Immunol. 206:1058. PubMed Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed Han Y et al. 2019. Cell reports. 27(3):835-846 . PubMed Zhang F, et al. 2019. Nat Commun. 10:3974. PubMed Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed Currier MA, et al. 2017. Oncotarget. 8:17412. PubMed Yang C, et al. 2020. J Control Release. 326:324. PubMed Cai B, et al. 2021. Mol Cancer. 20:165. PubMed Linnerbauer M, et al. 2022. Front Immunol. 12:800128. PubMed Bresque M, et al. 2022. J Biol Chem. :101711. PubMed Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed Kovács B, et al. 2020. Front Immunol. 2.508333333. PubMed Anderson MC, et al. 2018. Cell Chem Biol. 25:483. PubMed Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed Gui J, et al. 2020. Nat Cancer. 1:603. PubMed Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed Woods T, et al. 2016. J Virol. 90: 2783 - 2793. PubMed Zhang J, et al. 2015. Sci Rep. 5: 15553. PubMed Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed Formaglio P, et al. 2021. Immunity. 54:2724. PubMed Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed Stutz MD, et al. 2021. Immunity. 54(8):1758-1771.e7. PubMed Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed Qi S et al. 2016. eLife. 5 pii: e14756. PubMed Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed Lu X, et al. 2015. J Immunol. 194:2011. PubMed Saha S, et al. 2016. Nat Commun. 7:13096. PubMed Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed Sefik E, et al. 2021. Nat Biotechnol. . PubMed Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed Wilson R, et al. 2016. Nat Commun. 7:13597. PubMed Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed Yu X, et al. 2019. Nat Commun. 10:574. PubMed Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed Wang SK, et al. 2021. JCI Insight. 6: . PubMed Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed Buzzelli JN, et al. 2019. Am J Physiol Gastrointest Liver Physiol. 316:G251. PubMed Andriessen EMMA, et al. 2021. EMBO Mol Med. 13:e11754. PubMed Kalafati L, et al. 2020. Cell. 183:771. PubMed Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed Yousef H, et al. 2019. Nat Med. 25:988. PubMed Briukhovetska D, et al. 2020. Frontiers in Immunology. 1.428472222. PubMed Franklin DA, et al. 2020. JCI Insight. 5:. PubMed Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed Ni Y, et al. 2021. Theranostics. 11:9431. PubMed Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed Zhang L, et al. 2020. Cell. 442:181. PubMed Lee MC, et al. 2017. J Immunol. 198:3565. PubMed Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed Sen D, et al. 2016. PLoS One. 11:e0165064. PubMed Woods PS, et al. 2020. Am J Respir Cell Mol Biol. 62:243. PubMed Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed Dodd RD, et al. 2017. Cancer Res. 77:4486. PubMed O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed Saleh R, et al. 2018. J Immunol. 201:2042. PubMed Lee A, et al. 2022. Nat Commun. 13:549. PubMed Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed Cai W, et al. 2019. J Neuroinflammation. 0.788194444. PubMed Qi S, et al. 2020. Theranostics. 10:1814. PubMed Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed Davis FM, et al. 2021. J Exp Med. 218:. PubMed
RRID: AB_10645331 (BioLegend Cat. No. 127623) AB_10640819 (BioLegend Cat. No. 127624)
Structure: A 21-35 kD GPI-anchorded membrane protein
Distribution: Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.
Cell Type: Granulocytes, Macrophages, Monocytes
Biology Area: Immunology, Innate Immunity
Antigen References: Fleming TJ, et al. 1993. J. Immunol. 151:2399.
Gene ID: 546644
UniProt: View information about Ly-6G on UniProt.org
Clone: 1A8
Regulatory Status: RUO
Other Names: Lymphocyte antigen 6 complex, locus G
Isotype: Rat IgG2a, κ